Amazon deepens healthcare push with $5 monthly subscription
12:08 JST, January 25, 2023
Amazon.com Inc AMZN.O said on Tuesday it is offering a $5 monthly subscription plan for U.S. Prime members that will cover a range of generic drugs and their doorstep delivery, furthering the ecommerce giant’s push into healthcare.
The program, named RxPass, includes more than 50 medications addressing over 80 chronic conditions such as high blood pressure, anxiety, diabetes and male pattern baldness, Vin Gupta, Amazon Pharmacy’s chief medical officer, told Reuters.
However, customers enrolled in Medicare, Medicaid or any other government healthcare program will not be able to enroll in Amazon Pharmacy’s RxPass service.
The average Prime member would save about $100 per year with RxPass, John Love, vice president of Amazon Pharmacy, said in an interview. Amazon Prime members in most U.S. states can sign up for the program from Tuesday.
The flat $5 charge would be without insurance and on top of the Prime membership fee, which costs $139 per year in the United States.
The new service aligns with Amazon’s ongoing focus on its healthcare portfolio, which over the recent years has included telehealth, drug delivery, fitness trackers, and cancer research.
Amazon’s purchase of online pharmacy PillPack in 2018 helped the retail giant set up a prescription delivery and price-comparison site. Now, its Pharmacy initiative poses a growing threat to drugstore retailers CVS Health Corp CVS.N and Walgreens Boots Alliance Inc WBA.O.
“We believe a lot of Americans, particularly those that suffer from a chronic illness, are going to benefit from just Amazon’s participation in pharmacy, the ability to get high-quality experience delivered to your door at low cost,” Love said.
"News Services" POPULAR ARTICLE
-
Christmas TV Movies Are in Their Taylor Swift Era, with Two Swift-inspired Films Airing This Year
-
Israel Strikes Suspected Chemical Weapons Sites and Long-range Rockets in Syria
-
Kadokawa Shares Surge after News of Sony Acquisition Talks
-
Japan’s Nikkei Stock Average Ends Higher as Chip-Related Shares Track Nasdaq Gains (UPDATE 1)
-
Japan’s Nikkei Stock Average Ends Higher in Choppy Trade (UPDATE 1)
JN ACCESS RANKING
- BOJ Policy Normalization to Support Long-Term Growth: Ueda
- APEC Leaders Vow to Maintain Free Trade System
- Malaysia Growing in Popularity as Destination for Studying Abroad; British-style Education Available at Low Cost
- Ministry Eyes Improving Night-School Japanese Lessons; Aim Is To Help Foreigners Complete Junior High School
- China to Test Mine for Rare Metals Off Japan Island; Japan Lagging in Technologies Needed for Extraction